U.S. Senate Hearing: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process
Celebrity Pictures > Archives > 2020 > June >
U.S. Senate Hearing: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process (35 pictures)
View All Images- Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo looks on during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Founder and CEO Valisure, David Light, looks on after a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Founder and CEO Valisure, David Light, speaks during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research Food and Drug Administration, Douglas Throckmorton speaks by video conference during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo speaks during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- United States Senator Chuck Grassley (Republican of Iowa) speaks with an aide during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin speaks during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Founder and CEO Valisure, David Light, looks on during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Founder and CEO Valisure, David Light, speaks during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- A woman looks on as President & Chief Executive Officer CivicaRx, Martin VanTrieste, speaks by video conference during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Founder and CEO Valisure, David Light, speaks during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Founder and CEO Valisure, David Light, looks on during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin speaks during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin speaks during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- United States Senator John Thune (Republican of South Dakota) adjusts his mask during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin speaks during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- United States Senator Chuck Grassley (Republican of Iowa) adjusts his mask before a US Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo speaks during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- United States Senator Ron Wyden (Democrat of Oregon) speaks by video conference during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- United States Senator John Thune (Republican of South Dakota) looks on during a US Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin looks on during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- United States Senator Ben Sasse (Republican of Nebraska) looks on during a US Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo speaks during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research Food and Drug Administration, Douglas Throckmorton M.D. speaks by video conference during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin looks on as Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo speaks during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- United States Senator Pat Toomey (Republican of Pennsylvania) asks a question by video conference during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin (R) and Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo look on during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- United States Senator Chuck Grassley (Republican of Iowa) arrives for a US Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo speaks during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo speaks during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Judith A. McMeekin, Pharm.D., Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs, Food and Drug Administration and Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo (L) look on during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- United States Senator John Cornyn (Republican of Texas) looks on during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- United States Senator Debbie Stabenow (Democrat of Michigan) asks a question by video conference during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- United States Senator John Cornyn (Republican of Texas) speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
- Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin and Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo look on during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020. Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia `